Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: A regional overview

International Journal of Drug Policy

Volumn 18, Issue 4, 2007, Pages 313-318

  Bobrova, Natalia ^a   Sarang, Anya ^b,c   Stuikyte, Raminta ^c   Lezhentsev, Konstantin ^d,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Russian Harm Reduction Network   (Russian Federation)

^c Central Eastern European Harm Reduction Network   (United Kingdom)

^d International Harm Reduction Development Programme   (United States)

^e All Ukrainian Network of People Living with HIV   (Ukraine)

Author keywords

ARV; Central and Eastern Europe and Central Asia; Drug users; HIV

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; ASIA; DRUG COST; EPIDEMIC; EUROPE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; STRUCTURED QUESTIONNAIRE; SUPERINFECTION;

ANTI-HIV AGENTS; ASIA, CENTRAL; EUROPE; HEALTH SERVICES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT REFUSAL; VULNERABLE POPULATIONS;

EID: 34547191789     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.01.015     Document Type: Article

References (21)

1. Altice F.L., Springer S., Buitrago M., Hunt D.P., and Friedland G.H. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users. Journal of Urban Health 80 (2003) 416-427
2. Andersen M., Paliwoda J., Kaczynski R., Schoener E., Harris C., Madeja C., et al. Integrating medical and substance abuse treatment for addicts living with HIV/AIDS: Evidence based nursing practice model. The American Journal of Drug and Alcohol Abuse 29 (2003) 847-859
3. Bobrova N., Rhodes T., Power R., Alcorn R., Neifeld E., Krasiukov N., et al. Barriers to accessing drug treatment in Russia: A qualitative study among injecting drug users in two cities. Drug Alcohol Dependence 82 (2006) S57-S63
4. Ciccio L. ART treatment in poor settings: State of the art. Health Policy and Development 2 (2004) 52-61
5. Clarke S., Delamere S., McCullough L., Hopkins S., Bergin C., and Mulcahy F. Assessing limiting factors to the acceptance of anti-retroviral therapy in a large cohort of injecting drug users. HIV Medicine 4 (2003) 33-37
6. EuroHIV (2006). HIV/AIDS Surveillance in Europe. Midyear report 2005. No. 72.
7. European AIDS Treatment Group (2003). Treatment preparedness for PLWHA in Ukraine.
8. Laguno M., Murillas J., Blanco J.L., Martinez E., Miquel R., Sanchez-Tapias J.M., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS 18 (2004) 27-36
9. Lezhenstev, K. (2004). Drug prices Ukraine-result of competition. CEEHRN Communication.
10. Lucas G.M., Weidle P.J., Hader S., and Moore R.D. Directly administered anti-retroviral therapy in an urban methadone maintenance clinic: A nonrandomized comparative study. Clinical Infectious Diseases 38 Suppl 5 (2004) S409-S413
11. Macalino G.E., Mitty J.A., Bazerman L.B., Singh K., McKenzie M., and Flanigan T. Modified directly observed therapy for the treatment of HIV-seropositive substance users: Lessons learned from a pilot study. Clinical Infectious Diseases 38 Suppl 5 (2004) S393-S397
12. Moatti J.P., Carrieri M.P., Spire B., Gastaut J.A., Cassuto J.P., and Moreau J. Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. AIDS 14 (2000) 151-155
13. Pach III A., Cerbone F.G., and Gerstein D.R. A qualitative investigation of anti-retroviral therapy among injecting drug users. AIDS and Behaviour 7 (2003) 87-100
14. Patrick D.M., Tyndall M.W., Cornelisse P.G., Li K., Sherlock C.H., Rekart M.L., et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Canadian Medical Association Journal 165 (2001) 889-895
15. Sorensen J.L., Mascovich A., Wall T.L., DePhilippis D., Batki S.L., and Chesney M. Medication adherence strategies for drug users with HIV/AIDS. AIDS Care 10 (1998) 297-312
16. Subata, E. (2002). Injecting Drug users, HIV/AIDS Treatment and primary care in Central and Eastern Europe and FSU-Results from a Region-wide survey. CEEHRN report.
17. Sullivan L.E., and Fiellin D.A. Hepatitis C and HIV infections: Implications for clinical care in injection drug users. The American Journal on Addictions 13 (2004) 1-20
18. World Health Organization. Progress on global access to HIV anti-retroviral therapy: An update on "3 by 5" (2005), WHO Press, Geneva, Switzerland
19. World Health Organization Regional Office for Europe (2003). Fact Sheet EURO/06/03. Copenhagen, Denmark: WHO.
20. World Health Organization Regional Office for Europe (2005). Fact sheet EURO/14/05. Copenhagen, Denmark: WHO.
21. Witteveen E., and van Ameijden E.J. Drug users and HIV-combination therapy (HAART): Factors which impede or facilitate adherence. Substance Use Misuse 37 (2002) 1905-1925